Bristol-Myers Squibb Company (NYSE:BMY) Q1 2024 Earnings Call Transcript
Yahoo Finance · 3 days ago
Open | 43.90 |
High | 44.33 |
Low | 43.69 |
Mkt Cap | 88.93B |
P/E (TTM) | N/A |
Div & Yield | 2.40 & 5.49% |
Prev. Close | 43.70 |
52 Wk. Low | 43.33 |
52 Wk. High | 69.10 |
Related stocks
American pharmaceutical company
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 11.87B | 4.70% ▲ |
Net Income | -11.91B | - |
Diluted EPS | -4.40 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $1.70 | - |
Q1 2024 | -$4.44 | -$4.40 |
Q4 2023 | $1.43 | $1.59 |
S&P 500^GSPC | 5,133.42+69.22 (+1.37%) |
Dow 30^DJI | 38,715.08+489.42 (+1.28%) |
Nasdaq^IXIC | 16,182.79+341.83 (+2.16%) |
74.25-6.53% | |
Apple Inc.AAPL | 185.80+7.38% |
74.11-16.70% |